Obese children without comorbidities have impaired microvascular endothelial function

P Hedvall Kallerman1, E Hagman, A-K Edstedt Bonamy

  • 1Divisions of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Insights

Obese children show impaired endothelium-dependent vasodilatation, a key indicator of vascular health. Longer duration of obesity was linked to less severe impairment in microvascular endothelial function.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Physiology
  • Vascular Biology

Background:

  • Childhood obesity is a growing public health concern.
  • Obesity is associated with endothelial dysfunction, a precursor to cardiovascular disease.
  • Microvascular endothelial function in obese children without comorbidities requires further investigation.

Purpose of the Study:

  • To assess acetylcholine-induced endothelium-dependent vasodilatation in obese children compared to normal-weight controls.
  • To explore associations between endothelial function and risk factors like lipids, glucose metabolism, inflammation, blood pressure, fitness, and obesity duration.

Main Methods:

  • Utilized transdermal iontophoresis of acetylcholine to induce endothelium-dependent vasodilatation.
  • Measured changes in skin perfusion using laser Doppler flowmetry.
  • Evaluated endothelial function in 54 obese children and 44 normal-weight controls, with subgroup analysis for risk factors.

Main Results:

  • Obese children exhibited significantly lower acetylcholine-induced vasodilatation compared to controls (p < 0.001).
  • Peak perfusion response was 33% lower in obese children (p = 0.001).
  • A trend of lower vasodilatation was observed with higher triglyceride levels (p = 0.07), and shortest obesity duration showed lowest vasodilatation (p = 0.03).

Conclusions:

  • Obese children, even without comorbidities, have demonstrably impaired microvascular endothelial function.
  • Longer duration of obesity may be associated with a less pronounced impairment of endothelial function.
  • Findings highlight the early impact of obesity on vascular health in children.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440